Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise. Danese S, Peyrin-Biroulet L. Inflamm Bowel Dis 2021 Jun 5. pii: 6293782. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Danese S, Peyrin-Biroulet L. Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise. Inflamm Bowel Dis 2021 Jun 5. pii: 6293782. doi: 10.1093.
PMID: 34089259